May 12, 2022UncategorizedGenzada Pharmaceuticals Opens Phase 1B Metastatic Breast Cancer TrialRead More
March 20, 2019Drug DevelopmentFirst Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02 from Genzada PharmaceuticalsRead More
November 20, 2018FDA ApprovalKansas Company Receives FDA Approval on Plant Derived Cancer TreatmentRead More
